| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/29/2006 | CN1753968A Antioxidative composition and composition for external use |
| 03/29/2006 | CN1753861A Novel aminobenzophenone compounds |
| 03/29/2006 | CN1753664A Skin-whitening composition |
| 03/29/2006 | CN1753656A Bioadhesive liquid composition which is substantially free of water |
| 03/29/2006 | CN1752085A Aromatic hydrazide kind compound and its use in preparation of immune inhibitor |
| 03/29/2006 | CN1751731A Traditional Chinese medicine soft capsule for clearing humidness toxicity and its prepn. method |
| 03/29/2006 | CN1751712A Traditional Chinese medicine for dispelling acne or pimples |
| 03/29/2006 | CN1751702A Specific prescription for treating ringworm nails and hand tinea |
| 03/29/2006 | CN1751699A Sofflower injection and its prepn. method |
| 03/29/2006 | CN1247780C Mammalian sytokine-like polypeptide-10 |
| 03/29/2006 | CN1247605C Novel galactosylceramide analogs and beta-glucocerebrosidase activators, external skin preparations and method of activating beta-glucocerebrosidase using the analogs |
| 03/29/2006 | CN1247589C Tricyclic derivatives of indole with antiangiogenic activity |
| 03/29/2006 | CN1247586C Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives for neurodegenerative disorders |
| 03/29/2006 | CN1247585C Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives |
| 03/29/2006 | CN1247584C I-[alkyl] 1-[(heteroaryl) alkyl] and 1 [(aryl) alkyl] 7-pyridinyl-imidazo [1,2-a] pyrimidin-5(1h)-one derivatives |
| 03/29/2006 | CN1247577C Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 03/29/2006 | CN1247576C Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/29/2006 | CN1247575C Sulfamino ether substituted imidazoquinolines |
| 03/29/2006 | CN1247573C Method for preparing arylacetyl aminothiazole |
| 03/29/2006 | CN1247570C Novel pyridyl cyanoguandine compounds |
| 03/29/2006 | CN1247567C 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors |
| 03/29/2006 | CN1247549C Benzotriazole compound and use thereof |
| 03/29/2006 | CN1247547C Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases |
| 03/29/2006 | CN1247511C Tropolone derivative |
| 03/29/2006 | CN1247256C Pharmaceutical combination for treatment of tissue damage owing to arterial irrigation defect |
| 03/29/2006 | CN1247243C Chinese herbal medicine cream for treating hand and foot rhagas |
| 03/29/2006 | CN1247240C Herbal medicine compositions for treatment allergic rhinitis and use thereof |
| 03/29/2006 | CN1247227C External-use liposome prepn for treating mite-borne dermatosis |
| 03/29/2006 | CN1247226C Externally applied medicinal formulation for regenerating hair |
| 03/29/2006 | CN1247216C External used Chinese medicinal ointment for scald and its preparation |
| 03/29/2006 | CN1247205C Sea cucumber carotenoid lipid fraction products and method of use |
| 03/29/2006 | CN1247204C Medicine for treating beri-beri |
| 03/29/2006 | CN1247192C Assay for identification of compound that promote meianin prodn. and retinoid-like compounds identified by said assay |
| 03/29/2006 | CN1247191C Hydroxy diphenyl ether compound |
| 03/29/2006 | CN1247182C Composition of component of skin whitening cosmetics |
| 03/28/2006 | US7019147 E.,g.,1-[2-(5-Methoxy-benzoimidazol-1-yl)-quinolin-8-yl]-piperidin-4-ylamine; anticarcinogenic and -tumor agent; KDR tyrosine kinase inhibitors; (KDR=kinase inserrt domain recepter) |
| 03/28/2006 | US7019108 Especially the amino acid sequence Ile-Phe-Ala-Gly-Asp-Lys-Phe-Trp-Arg, preferably flanked by cysteine residues at the amino and carboxy termini. |
| 03/28/2006 | US7019029 Topically administering 3,4-dihydroxy,5-(phenylalkyl)-2,5-dihydrofuran-2-one derivatives of given formula; inhibits tyrosinase or tyrosine phosphatase |
| 03/28/2006 | US7019026 Modulators of Protein Tyrosine Phosphatases (PTPases) |
| 03/28/2006 | US7019007 CCR-3 receptor antagonists (I) |
| 03/28/2006 | US7019006 Compounds useful as anti-inflammatory agents |
| 03/28/2006 | US7018994 Antiestrogen compound |
| 03/28/2006 | US7018993 Androstane derivatives having various substituents at positions 7 and/or 11, a prophylactic or therapeutic agent for a disease selected from prostate cancer, benign prostatic hyperplasia, alopecia, acne, precocioous puberty |
| 03/28/2006 | US7018985 Composition and method for inhibiting platelet aggregation |
| 03/28/2006 | US7018624 Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels |
| 03/28/2006 | CA2395186C Procollagen c-proteinase inhibitors |
| 03/28/2006 | CA2386793C New selective retinoid agonists |
| 03/28/2006 | CA2343459C Pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/28/2006 | CA2309551C Aminothiazole inhibitors of cyclin dependent kinases |
| 03/28/2006 | CA2209696C Use of a polysaccharide in a composition designed to stimulate the immune defences, and the composition in which it is included |
| 03/28/2006 | CA2106719C Reshaped monoclonal antibodies against an immunoglobulin isotype |
| 03/23/2006 | WO2006031922A2 Thyroid hormone analogs for promoting angiogenesis |
| 03/23/2006 | WO2006031786A2 Protein a compositions and methods of use |
| 03/23/2006 | WO2006031772A1 Methods of treating proliferative skin diseases using carbazole derivatives |
| 03/23/2006 | WO2006031738A1 Methods for treating open wounds |
| 03/23/2006 | WO2006031142A1 Biologically active material, method for the production thereof and a therapeutic agent based thereon |
| 03/23/2006 | WO2006030887A1 External preparation for treating skin ulcer |
| 03/23/2006 | WO2006030693A1 Agents for overcoming hair troubles and method of screening the same |
| 03/23/2006 | WO2005011663A8 Use of a biguanide derivative for protecting skin against uvb radiation |
| 03/23/2006 | US20060063940 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 03/23/2006 | US20060063934 Pyrazole compounds |
| 03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |
| 03/23/2006 | US20060063835 Composition based on triethyl citrate for the treatment of bacterial infections of the skin |
| 03/23/2006 | US20060063809 Tri-substituted heteroaryls and methods of making and using the same |
| 03/23/2006 | US20060063789 Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors |
| 03/23/2006 | US20060063782 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
| 03/23/2006 | US20060063778 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 03/23/2006 | US20060063771 CCR5 antagonists useful for treating AIDS |
| 03/23/2006 | US20060063763 Compounds and methods for modulating CXCR3 function |
| 03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 03/23/2006 | US20060063235 DNA encoding the human serine protease C-E |
| 03/23/2006 | US20060062807 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 03/23/2006 | US20060062777 Inhibit tumor growth, or metastasis by modifying protein-protein interactions involving certain amino acid sequences within matrix metalloproteinase 9 (MMP-9) |
| 03/23/2006 | US20060062771 Therapeutic autologous-cell delivery support system, financial system for use therewith, and method therefor |
| 03/23/2006 | DE102004045720A1 Stabile Dosierungsform von Phenylalanin-Derivaten Stable dosage form of phenylalanine derivatives |
| 03/23/2006 | CA2584553A1 External agent for treatment of skin ulcer |
| 03/23/2006 | CA2583410A1 Thyroid hormone analogs for promoting angiogenesis |
| 03/23/2006 | CA2580804A1 Compositions and methods for inducing hair growth |
| 03/23/2006 | CA2580517A1 Protein a compositions and methods of use |
| 03/23/2006 | CA2580107A1 Growth factor treatment for asthma |
| 03/23/2006 | CA2577024A1 Methods of treating proliferative skin diseases using carbazole derivatives |
| 03/22/2006 | EP1637589A1 Novel stem cell derived from adult tissue and use thereof |
| 03/22/2006 | EP1637533A1 Substituted thiazolopyrimidines as analgetics |
| 03/22/2006 | EP1637521A1 Novel tricyclic heterocycle compound |
| 03/22/2006 | EP1637162A1 MEDICINAL COMPOSITION FOR PREVENTING OR TREATING Th1 TYPE IMMUNOLOGICAL DISEASE |
| 03/22/2006 | EP1637160A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 03/22/2006 | EP1637148A1 Novel therapeutic use of polypodium extracts |
| 03/22/2006 | EP1637145A1 Material promoting wound healing |
| 03/22/2006 | EP1637143A1 Sulfacetamide formulations further containing a sunscreen for treatment of rosacea |
| 03/22/2006 | EP1637139A2 Novel use of HIV protease inhibiting compounds |
| 03/22/2006 | EP1637135A1 Compositions comprising dimethylsulfoxide and tretinoin for treating skin disorders |
| 03/22/2006 | EP1637132A1 External preparation for athlete´s foot treatment |
| 03/22/2006 | EP1636228A1 Novel pyridopyrazines and use thereof as kinase modulators |
| 03/22/2006 | EP1636211A1 3-arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents |
| 03/22/2006 | EP1635910A1 Cosmetic and/or dermatological preparations containing an extract from the seeds of plants of the genus adenanthera |
| 03/22/2006 | EP1635891A2 Pharmaceutical composition to prevent and treat epithelial wounds, immunomodulating pharmaceutical composition, pharmaceutical composition, insecticide, insecticide composition, insecticide use of lectin km+ to treat cicatrizations, use of lectin km+ to prepare immunomodulating medicament |
| 03/22/2006 | EP1635852A1 Nail restructuring compositions for topical application |
| 03/22/2006 | EP1635850A1 Antimicrobial silver comprising silver |
| 03/22/2006 | EP1635798A2 Inhibitors of histone deacetylases for the suppression therapy of diseases |
| 03/22/2006 | EP1635776A1 Lipidic protein-transfer systems and cosmetic/dermatological use thereof |